General Article Scientists disagree about the ethics and governance of human germline editing

Topic Selected: Biotech and Bioethics Book Volume: 352
This article is 5 years old. Click here to view the latest articles for this topic.

By Francoise Baylis and Marcy Darnovsky

Despite the appearance of agreement, scientists are not of the same mind about the ethics and governance of human germline editing. A careful review of public comments and published commentaries in top-tier science journals reveals marked differences in perspective. These divergences have significant implications for research practice and policy concerning heritable human genome editing.

The current chapter in the debate about the societal and political implications of human germline editing took off nearly four years ago, in response to a laboratory experiment in which researchers in China used CRISPR technology on nonviable human embryos. In March 2015, an article titled Don’t Edit the Human Germline, coauthored by scientists and others working on somatic cell genome editing and associated with the Alliance for Regenerative Medicine, appeared in the comment section of Nature. A week later, Science published a ‘Perspective’ commentary coautho...

Would you like to see the rest of this article and all the other benefits that Issues Online can provide with?

Sign up now for an immediate no obligation FREE TRIAL and view the entire collection